Seroquel XR in Schizophrenia Relapse Prevention
This study has been completed.
Sponsor:
AstraZeneca
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00990626
First received: October 1, 2009
Last updated: November 16, 2010
Last verified: November 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of the study is to determine whether the Seroquel XR treatment for 6 months improve the relapse prevention in schizophrenic outpatients
| Condition |
|---|
|
Schizophrenia Relapse Prevention |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Seroquel XR in Schizophrenia Relapse Prevention |
Resource links provided by NLM:
Further study details as provided by AstraZeneca:
Primary Outcome Measures:
- Rate of patients remained relapse free after 6 months of treatment [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Adherence rate of patients [ Designated as safety issue: No ]
- Quality of Life (QoL ) [ Designated as safety issue: No ]
| Estimated Enrollment: | 1600 |
| Study Start Date: | October 2009 |
| Study Completion Date: | July 2010 |
| Primary Completion Date: | July 2010 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
1
Schizophrenic outpatients
|
Eligibility| Ages Eligible for Study: | 18 Years to 70 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
Psychiatric outpatient clinics
Criteria
Inclusion Criteria:
- Schizophrenic outpatients on at least 600 mg Seroquel XR treatment for at least 1 month
Exclusion Criteria:
- Severe cerebro- and cardiovascular disease, severe hepatic impairment, gravidity
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00990626
Locations
| Hungary | |
| Research Site | |
| Baja, Hungary | |
| Research Site | |
| Barcs, Hungary | |
| Research Site | |
| Budapest, Hungary | |
| Research Site | |
| Cegled, Hungary | |
| Research Site | |
| Debrecen, Hungary | |
| Research Site | |
| Dombovar, Hungary | |
| Research Site | |
| Dunaujvaros, Hungary | |
| Research Site | |
| Eger, Hungary | |
| Research Site | |
| Egerszalok, Hungary | |
| Research Site | |
| Emod, Hungary | |
| Research Site | |
| Erd, Hungary | |
| Research Site | |
| Esztergom, Hungary | |
| Research Site | |
| Godollo, Hungary | |
| Research Site | |
| Gyongyos, Hungary | |
| Research Site | |
| Gyor, Hungary | |
| Research Site | |
| Gyula, Hungary | |
| Research Site | |
| Heves, Hungary | |
| Research Site | |
| Hodmezovasarhely, Hungary | |
| Research Site | |
| Janoshalma, Hungary | |
| Research Site | |
| Jaszbereny, Hungary | |
| Research Site | |
| Kalocsa, Hungary | |
| Research Site | |
| Kecskemet, Hungary | |
| Research Site | |
| Ketegyhaza, Hungary | |
| Research Site | |
| Kiskunhalas, Hungary | |
| Research Site | |
| Kistokaj, Hungary | |
| Research Site | |
| Miskolc, Hungary | |
| Research Site | |
| Nagyatad, Hungary | |
| Research Site | |
| Nagykallo, Hungary | |
| Research Site | |
| Nagykanizsa, Hungary | |
| Research Site | |
| Nagykoros, Hungary | |
| Research Site | |
| Oroshaza, Hungary | |
| Research Site | |
| Pecs, Hungary | |
| Research Site | |
| Pomaz, Hungary | |
| Research Site | |
| Satoraljaujhely, Hungary | |
| Research Site | |
| Soltvadkert, Hungary | |
| Research Site | |
| Sopron, Hungary | |
| Research Site | |
| Sumeg, Hungary | |
| Research Site | |
| Szeged, Hungary | |
| Research Site | |
| Szeghalom, Hungary | |
| Research Site | |
| Szekesfehervar, Hungary | |
| Research Site | |
| Szekszard, Hungary | |
| Research Site | |
| Szentes, Hungary | |
| Research Site | |
| Szigetszentmiklos, Hungary | |
| Research Site | |
| Szigetvar, Hungary | |
| Research Site | |
| Szolnok, Hungary | |
| Research Site | |
| Szombathely, Hungary | |
| Research Site | |
| Tatabanya, Hungary | |
| Research Site | |
| Veszprem, Hungary | |
Sponsors and Collaborators
AstraZeneca
Investigators
| Principal Investigator: | Attila Németh | National Psychiatric Centre |
| Study Chair: | Lilla Szabó | AstraZeneca Hungary MC |
| Study Director: | Tamás Bábel | AstraZeneca Hungary MC |
More Information
No publications provided
| Responsible Party: | MC MD, AstraZeneca |
| ClinicalTrials.gov Identifier: | NCT00990626 History of Changes |
| Other Study ID Numbers: | NIS-NHU-SER-2009/1 |
| Study First Received: | October 1, 2009 |
| Last Updated: | November 16, 2010 |
| Health Authority: | Hungary: National Institute of Pharmacy |
Keywords provided by AstraZeneca:
|
Seroquel XR schizophrenia relapse prevention |
Additional relevant MeSH terms:
|
Recurrence Schizophrenia Disease Attributes Pathologic Processes Schizophrenia and Disorders with Psychotic Features Mental Disorders Quetiapine Antipsychotic Agents |
Tranquilizing Agents Central Nervous System Depressants Physiological Effects of Drugs Pharmacologic Actions Central Nervous System Agents Therapeutic Uses Psychotropic Drugs |
ClinicalTrials.gov processed this record on May 23, 2013